Ceritinib (Zykadia)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ceritinib (Zykadia), covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study [Phase 4]